Assessing risks posed by the innate immune response modulating and the toxicity of the cellular product
29 Oct 2024
Immunogenicity
- Can the immune system barrier for allogenic therapy and for vector based therapies be overcome ?
- Can universal cells be produced safely ?
- Can gene vectors be designed to escape the immune response ?
- Will these be game changers in the field?
Industry Experts
